active ingredient semaglutide in Ozempic, Wegovy shows early promise for treating alcohol use disorder among those with obesity: Study Semaglutide Claim Eligibility for Injured

In patients with type 2 diabetes (T2D), oral semaglutide matches sodiumglucose cotransporter 2 (SGLT2) inhibitors for blood sugar and weight reduction while better preserving skeletal muscle mass, as deciphered from the outcomes of a study published in "Journal of Diabetes Investigation"

In research on weight-loss diets, higher protein intake is consistently associated with better lean mass retention than lower protein intake, especially during calorie deficits

Improved understanding of the gut-brain axis has inspired the pursuit of novel medications aiming to provide sustainable and safe weight loss

Amazon's 24/7 on-demand telehealth service is exclusively for renewal of existing GLP-1 prescriptions where the patient has taken their medication within the past two weeks and is not requesting a dose change